182 related articles for article (PubMed ID: 25411843)
1. Assessing progress in reducing the at-risk population after 13 years of the global programme to eliminate lymphatic filariasis.
Hooper PJ; Chu BK; Mikhailov A; Ottesen EA; Bradley M
PLoS Negl Trop Dis; 2014 Nov; 8(11):e3333. PubMed ID: 25411843
[TBL] [Abstract][Full Text] [Related]
2. Elimination of lymphatic filariasis as a public health problem in Malawi.
Chiphwanya J; Mkwanda S; Kabuluzi S; Mzilahowa T; Ngwira B; Matipula DE; Chaponda L; Ndhlova P; Katchika P; Mahebere Chirambo C; Moses P; Kumala J; Chiumia M; Barrett C; Betts H; Fahy J; Rebollo Polo M; Reimer L; Stanton MC; Thomas B; Freer S; Molyneux DH; Bockarie MJ; Mackenzie CD; Taylor MJ; Martindale S; Kelly-Hope LA
PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011957. PubMed ID: 38363794
[TBL] [Abstract][Full Text] [Related]
3. What Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of Scaling Up Mass Drug Administration Programs.
Kastner RJ; Stone CM; Steinmann P; Tanner M; Tediosi F
PLoS Negl Trop Dis; 2015; 9(10):e0004147. PubMed ID: 26451729
[TBL] [Abstract][Full Text] [Related]
4. Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease.
Ramaiah KD; Ottesen EA
PLoS Negl Trop Dis; 2014 Nov; 8(11):e3319. PubMed ID: 25412180
[TBL] [Abstract][Full Text] [Related]
5. The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).
Chu BK; Hooper PJ; Bradley MH; McFarland DA; Ottesen EA
PLoS Negl Trop Dis; 2010 Jun; 4(6):e708. PubMed ID: 20532228
[TBL] [Abstract][Full Text] [Related]
6. A refined and updated health impact assessment of the Global Programme to Eliminate Lymphatic Filariasis (2000-2020).
Turner HC; Ottesen EA; Bradley MH
Parasit Vectors; 2022 May; 15(1):181. PubMed ID: 35643508
[TBL] [Abstract][Full Text] [Related]
7. The role of medicine donations in the global programme for the elimination of lymphatic filariasis.
Williams T; Taylor R; Iwamoto M; Hida T; Gusovsky F
Int Health; 2020 Dec; 13(Suppl 1):S39-S43. PubMed ID: 33349878
[TBL] [Abstract][Full Text] [Related]
8. Setting the stage for a Global Programme to Eliminate Lymphatic Filariasis: the first 125 years (1875-2000).
Ottesen EA; Horton J
Int Health; 2020 Dec; 13(Suppl 1):S3-S9. PubMed ID: 33349877
[TBL] [Abstract][Full Text] [Related]
9. Progress and impact of 20 years of a lymphatic filariasis elimination programme in South-East Asia.
Kapa DR; Mohamed AJ
Int Health; 2020 Dec; 13(Suppl 1):S17-S21. PubMed ID: 33349881
[TBL] [Abstract][Full Text] [Related]
10. How Thailand eliminated lymphatic filariasis as a public health problem.
Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
[TBL] [Abstract][Full Text] [Related]
11. Evolution of the monitoring and evaluation strategies to support the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis.
Lammie PJ; Gass KM; King J; Deming MS; Addiss DG; Biswas G; Ottesen EA; Henderson R
Int Health; 2020 Dec; 13(Suppl 1):S65-S70. PubMed ID: 33349883
[TBL] [Abstract][Full Text] [Related]
12. The global programme to eliminate lymphatic filariasis: health impact after 8 years.
Ottesen EA; Hooper PJ; Bradley M; Biswas G
PLoS Negl Trop Dis; 2008 Oct; 2(10):e317. PubMed ID: 18841205
[TBL] [Abstract][Full Text] [Related]
13. Elimination of lymphatic filariasis as a public health problem from the Arab Republic of Egypt.
Ramzy RMR; Kamal HA; Hassan MA; Haggag AA
Acta Trop; 2019 Nov; 199():105121. PubMed ID: 31400299
[TBL] [Abstract][Full Text] [Related]
14. Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China.
Fang Y; Zhang Y
Infect Dis Poverty; 2019 Aug; 8(1):66. PubMed ID: 31387644
[TBL] [Abstract][Full Text] [Related]
15. How much will it cost to eradicate lymphatic filariasis? An analysis of the financial and economic costs of intensified efforts against lymphatic filariasis.
Kastner RJ; Sicuri E; Stone CM; Matwale G; Onapa A; Tediosi F
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005934. PubMed ID: 28949987
[TBL] [Abstract][Full Text] [Related]
16. Sustained reduction in prevalence of lymphatic filariasis infection in spite of missed rounds of mass drug administration in an area under mosquito nets for malaria control.
Njenga SM; Mwandawiro CS; Wamae CN; Mukoko DA; Omar AA; Shimada M; Bockarie MJ; Molyneux DH
Parasit Vectors; 2011 May; 4():90. PubMed ID: 21612649
[TBL] [Abstract][Full Text] [Related]
17. Progress in the elimination of lymphatic filariasis in the Western Pacific Region: successes and challenges.
Yajima A; Ichimori K
Int Health; 2020 Dec; 13(Suppl 1):S10-S16. PubMed ID: 33349886
[TBL] [Abstract][Full Text] [Related]
18. Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis.
Krentel A; Gyapong M; McFarland DA; Ogundahunsi O; Titaley CR; Addiss DG
Int Health; 2020 Dec; 13(Supplement_1):S55-S59. PubMed ID: 33349882
[TBL] [Abstract][Full Text] [Related]
19. Information technology in morbidity management of human lymphatic filariasis-A promising tool in global programme for elimination of lymphatic filariasis.
Devi RR; Raju V
J Vector Borne Dis; 2018; 55(1):20-25. PubMed ID: 29916444
[TBL] [Abstract][Full Text] [Related]
20. The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).
Hooper PJ; Bradley MH; Biswas G; Ottesen EA
Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S17-21. PubMed ID: 19843394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
